The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve

2014-07-23 21:08:59 | BioPortfolio


This prospective study evaluates the effect of DHEA supplementation on markers of ovarian reserve in women with diminished ovarian reserve.


Ovarian reserve markers, such as FSH, estradiol, AMH, ovarian volume and antral follicle counts will be monitored on DHEA supplementation in a prospective fashion.

Study Design

Allocation: Non-Randomized, Control: Uncontrolled, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Women With Diminished Ovarian Reserve




Virginia Center for Reproductive Medicine
United States




Virginia Center for Reproductive Medicine

Results (where available)

View Results


Published on BioPortfolio: 2014-07-23T21:08:59-0400

Clinical Trials [1573 Associated Clinical Trials listed on BioPortfolio]

Follicular Activation by Fragmentation of Ovarian Tissue

The primary objective of this study is to assess the chances of increasing the number of antral follicles in ovarian tissue of patients with diminished ovarian reserve by activation of pri...

Thalidomide Results in Diminished Ovarian Reserve in Reproductive Age Female IBD Patients

The effectiveness of thalidomide in treating inflammatory bowel disease has been widely recognized. Meanwhile, many serious adverse drug reactions were notified, but no reports on ovaria...

The Use of DHEA in Women With Premature Ovarian Failure

DHEA supplementation has been used in women with infertility and diminished ovarian reserve. There is a small report in 5 women with POF that benefited from the use of DHEA over several mo...

Dehydroepiandrosterone (DHEA) Treatment and Premature Ovarian Failure (POF)

The experimental focus of this project is on the interaction of DHEA treatment on pregnancy in women with open tubes, fertile male partners and evidence of premature ovarian failure.

Follicle Activation by Inhibition of the Hippo Pathway

The aim of this project is to activate recruitment and growth of resting primordial follicles in the ovaries of women with diminished ovarian reserve, in attempt to increase the chance to ...

PubMed Articles [6971 Associated PubMed Articles listed on BioPortfolio]

Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF?

Ovarian reserve evaluation has been the focus of substantial clinical research for several years. This study aimed to examine the associations between markers of ovarian reserve and ovarian response.

Effect of dehydroepiandrosterone on the liver of perimenopausal rat: multiple doses study.

Dehydroepiandrosterone (DHEA) is a widespread nutritional "anti-aging" supplement. Exogenous supplementation of DHEA is now being commonly used to augment ovarian stimulation in perimenopausal women w...

Postponing Childbearing and Fertility Preservation in Young Professional Women.

To evaluate young women's awareness of ovarian reserve testing and oocyte cryopreservation (OC) and assess how testing ovarian reserve may affect the desire for fertility preservation.

Latent genital tuberculosis adversely affects the ovarian reserve in infertile women.

What is the effect of latent genital tuberculosis (GTB) on ovarian reserve in infertile women?

Endometrioma-related reduction in ovarian reserve (ERROR): a prospective longitudinal study.

To evaluate whether endometrioma is associated with a progressive decline in ovarian reserve, and to compare the rate of decline with natural decline in ovarian reserve.

Medical and Biotech [MESH] Definitions

Capacity of the ovary to provide viable eggs.

A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.

Men and women serving on active duty in the military, or in a reserve military force, and their immediate family including spouses, children, and parents.

The period before MENOPAUSE. In premenopausal women, the climacteric transition from full sexual maturity to cessation of ovarian cycle takes place between the age of late thirty and early fifty.

Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections.

More From BioPortfolio on "The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve"

Quick Search


Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Searches Linking to this Trial